SCHEMBL14938320

SCHEMBL14938320

CCN(C(=O)NN1CCNC1)c1ccncc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MLYCD O95822 1/20 0.34
GNAI3 P08754 1/20 0.34
GNAO1 P09471 1/20 0.34
GNAI1 P63096 1/20 0.34
QPCT Q16769 1/20 0.33
ACHE P22303 1/20 0.33
NAMPT P43490 1/20 0.33
HTT P42858 1/20 0.33
MAPKAPK2 P49137 3/20 0.32
ALDH1A1 P00352 2/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32
ADRB2 P07550 1/20 0.32
NCF1 P14598 1/20 0.32
PLD1 Q13393 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
IKBKE Q14164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14938327 0.87 MEN1 (0.50) MEN1KMT2AHTTALDH1A1GLA
SCHEMBL14938311 0.78 CHRM2 (0.33) GNAI3GNAO1GNAI1ALDH1A1TSHR
SCHEMBL22609141 0.72 KMT2A (0.47) MEN1KMT2AMLYCDHTTALDH1A1
SCHEMBL27858074 0.68 ALDH1A1 (0.53) MEN1KMT2AMLYCDHTTALDH1A1
SCHEMBL14938321 0.68 RAB9A (0.39) NAMPTHTTIKBKETBK1POLB
SCHEMBL31287336 0.66 GNAI3 (0.34) GNAI3GNAO1GNAI1
SCHEMBL29723856 0.65 MLYCD (0.46) MEN1KMT2AMLYCDHTTALDH1A1
SCHEMBL10600054 0.64 GNAI3 (0.49) GNAI3GNAO1GNAI1OPRM1OPRD1
SCHEMBL27919555 0.62 GNAI3 (0.37) GNAI3GNAO1GNAI1
SCHEMBL3802266 0.62 KMT2A (0.41) MEN1KMT2AGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123215-A1 2,5-DIOXOIMIDAZOLIDIN-1-YL-3-PHENYLUREA DERIVATIVES AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-05-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123215-A1 2,5-DIOXOIMIDAZOLIDIN-1-YL-3-PHENYLUREA DERIVATIVES AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS FPR1, FPR2, FPR3 MEN1 4449/4885KMT2A 4728/4885MLYCD 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.